Sutent 12.5 mg (Sunitinib (Sunitinib Malate) CAPSULE) 12.5 MG

Sunitinib (Sutent) 12.5 mg capsules are a cancer treatment medication used to target specific proteins in cancer cells. This oral medication is designed to inhibit tumor growth and is commonly prescribed for certain types of cancer.

Strength

12.5 MG

Pack Size

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Sunitinib (Sutent) 12.5 mg capsules are primarily used in the treatment of advanced kidney cancer (renal cell carcinoma) and gastrointestinal stromal tumors (GIST). This medication works by targeting specific proteins involved in the growth and spread of cancer cells. Patients may wonder, 'What is Sunitinib used for?' It is also used in the treatment of pancreatic neuroendocrine tumors and other types of cancer as determined by a healthcare provider.

Side Effects

Common effects of Sunitinib (Sutent) 12.5 mg capsules may include fatigue, nausea, diarrhea, and changes in skin color. Some users may experience appetite loss, vomiting, or hand-foot syndrome, which can cause redness, swelling, or peeling of the skin on the palms and soles. These effects can vary from person to person.

Precautions & Warnings

Sunitinib (Sutent) 12.5 mg capsules should be handled with care and stored as directed. It is important to follow the advice of a healthcare provider regarding administration and to report any severe or persistent side effects. This medication should not be used without medical supervision.

Avoid Interactions

Sunitinib (Sutent) 12.5 mg capsules may interact with certain medications, including those metabolized by the liver's CYP3A4 enzyme. It is advisable to inform a healthcare provider about all current medications, including over-the-counter drugs and supplements, to avoid potential interactions. Alcohol consumption should be discussed with a healthcare provider.

Frequently Asked Questions

Sunitinib is used to treat certain types of cancer, including kidney cancer, gastrointestinal stromal tumors, and pancreatic neuroendocrine tumors.

Sunitinib 12.5 mg capsules are typically taken orally, with or without food, as directed by a healthcare provider.

Common side effects may include fatigue, nausea, diarrhea, and changes in skin color. Severe or persistent effects should be reported to a healthcare provider.

Sunitinib may interact with certain medications, so it is important to consult a healthcare provider before combining it with other drugs.

If a dose is missed, it should be taken as soon as possible unless it is almost time for the next dose. Always follow the advice of a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.